Home » Topics » BioWorld Science

BioWorld Science
RSS

PDS Biotechnology presents phase I data for its novel immunotherapy PDS-0101

Sep. 20, 2019

CinDome Pharma initiates phase II study of deuterated domperidone

Sep. 20, 2019

Researchers unveil the role of vasorin in angiogenesis and tumor progression in glioma

Sep. 20, 2019

Rare eye disease gives clues to peripheral neuropathy

Sep. 20, 2019

CAR relative CCR may offer targeting advantages

Sep. 20, 2019

Bone-deep stress

Sep. 20, 2019

Exosome-derived miRNAs from colon cancer cells promote fibroblast proliferation and tumor growth

Sep. 20, 2019

BeiGene studies BGB-A1217 with tislelizumab in advanced solid tumors

Sep. 19, 2019

Alzprotect cleared to begin French phase IIa trial of AZP-2006 in progressive supranuclear palsy

Sep. 19, 2019

Onxeo reports initial data from first part of phase Ib DRIIV study of AsiDNA

Sep. 19, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...